Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient.
Iran J Allergy Asthma Immunol
; 22(5): 504-509, 2023 Oct 29.
Article
en En
| MEDLINE
| ID: mdl-38085151
Most patients with X-linked agammaglobulinemia are susceptible to infections, while some cases also suffer from inflammatory or autoimmune complications. We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Agammaglobulinemia
/
Enfermedades Genéticas Ligadas al Cromosoma X
/
Encefalitis
Límite:
Humans
Idioma:
En
Revista:
Iran J Allergy Asthma Immunol
Asunto de la revista:
ALERGIA E IMUNOLOGIA
Año:
2023
Tipo del documento:
Article
País de afiliación:
México
Pais de publicación:
Irán